The antimalarial drug mefloquine enhances TP53 premature termination codon readthrough by aminoglycoside G418

Nonsense mutations constitute ~10% of TP53 mutations in cancer. They introduce a premature termination codon that gives rise to truncated p53 protein with impaired function. The aminoglycoside G418 can induce TP53 premature termination codon readthrough and thus increase cellular levels of full-leng...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:PLoS One
Autors principals: Ferguson, Michael W., Gerak, Chloe A. N., Chow, Christalle C. T., Rastelli, Ettore J., Elmore, Kyle E., Stahl, Florian, Hosseini-Farahabadi, Sara, Baradaran-Heravi, Alireza, Coltart, Don M., Roberge, Michel
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2019
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6532957/
https://ncbi.nlm.nih.gov/pubmed/31120902
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0216423
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars